<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en-GB">
	<id>https://stockhub.co/index.php?action=history&amp;feed=atom&amp;title=Medifron_DBT_Co.%2C_Ltd.</id>
	<title>Medifron DBT Co., Ltd. - Revision history</title>
	<link rel="self" type="application/atom+xml" href="https://stockhub.co/index.php?action=history&amp;feed=atom&amp;title=Medifron_DBT_Co.%2C_Ltd."/>
	<link rel="alternate" type="text/html" href="https://stockhub.co/index.php?title=Medifron_DBT_Co.,_Ltd.&amp;action=history"/>
	<updated>2026-05-27T06:42:59Z</updated>
	<subtitle>Revision history for this page on the wiki</subtitle>
	<generator>MediaWiki 1.43.5</generator>
	<entry>
		<id>https://stockhub.co/index.php?title=Medifron_DBT_Co.,_Ltd.&amp;diff=67826&amp;oldid=prev</id>
		<title>95.149.241.133: Created page with &quot;== Summary&lt;ref&gt;Source: Yahoo Finance.&lt;/ref&gt; ==  Medifron DBT Co., Ltd., a clinical stage biopharmaceutical company, focuses on the development of Alzheimer&#039;s disease (AD) and neuropathic pain treatments, and AD diagnostics. The company was formerly known as Legend Technologies Inc. and changed its name to Medifron DBT Co., Ltd. in 2006. Medifron DBT Co., Ltd. was incorporated in 1997 and is based in Seoul, South Korea.  == References and notes ==  Category:Thesis __I...&quot;</title>
		<link rel="alternate" type="text/html" href="https://stockhub.co/index.php?title=Medifron_DBT_Co.,_Ltd.&amp;diff=67826&amp;oldid=prev"/>
		<updated>2022-09-22T08:19:27Z</updated>

		<summary type="html">&lt;p&gt;Created page with &amp;quot;== Summary&amp;lt;ref&amp;gt;Source: Yahoo Finance.&amp;lt;/ref&amp;gt; ==  Medifron DBT Co., Ltd., a clinical stage biopharmaceutical company, focuses on the development of Alzheimer&amp;#039;s disease (AD) and neuropathic pain treatments, and AD diagnostics. The company was formerly known as Legend Technologies Inc. and changed its name to Medifron DBT Co., Ltd. in 2006. Medifron DBT Co., Ltd. was incorporated in 1997 and is based in Seoul, South Korea.  == References and notes ==  &lt;a href=&quot;/research/Category:Thesis&quot; title=&quot;Category:Thesis&quot;&gt;Category:Thesis&lt;/a&gt; __I...&amp;quot;&lt;/p&gt;
&lt;p&gt;&lt;b&gt;New page&lt;/b&gt;&lt;/p&gt;&lt;div&gt;== Summary&amp;lt;ref&amp;gt;Source: Yahoo Finance.&amp;lt;/ref&amp;gt; ==&lt;br /&gt;
&lt;br /&gt;
Medifron DBT Co., Ltd., a clinical stage biopharmaceutical company, focuses on the development of Alzheimer&amp;#039;s disease (AD) and neuropathic pain treatments, and AD diagnostics. The company was formerly known as Legend Technologies Inc. and changed its name to Medifron DBT Co., Ltd. in 2006. Medifron DBT Co., Ltd. was incorporated in 1997 and is based in Seoul, South Korea.&lt;br /&gt;
&lt;br /&gt;
== References and notes == &lt;br /&gt;
[[Category:Thesis]]&lt;br /&gt;
__INDEX__&lt;/div&gt;</summary>
		<author><name>95.149.241.133</name></author>
	</entry>
</feed>